Holen Sie sich die Stockscreener-App
36.17
1.06%
0.38
Schlusskurs vom Vortag:
$35.79
Offen:
$36.14
24-Stunden-Volumen:
269.65K
Relative Volume:
0.49
Marktkapitalisierung:
$1.75B
Einnahmen:
$447.57M
Nettoeinkommen (Verlust:
$-38.92M
KGV:
-66.98
EPS:
-0.54
Netto-Cashflow:
$-1.15M
1W Leistung:
+0.39%
1M Leistung:
+29.50%
6M Leistung:
+55.97%
1J Leistung:
-13.88%
1-Tages-Spanne:
$35.91
$36.47
1-Wochen-Bereich:
$34.93
$36.70
52-Wochen-Spanne:
$18.94
$42.98
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
36.17 | 1.75B | 447.57M | -38.92M | -1.15M | -0.54 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.04 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 52,533 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 31,366 AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Trend Tracker for (ATRC) - Stock Traders Daily
AtriCure Inc. loses $24 million in value following the election (See how it affected others) - The Business Journals
AtriCure to Present at Piper Sandler Healthcare Conference in December | ATRC Stock News - StockTitan
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives $43.11 Average Price Target from Analysts - MarketBeat
What to Expect from AtriCure - AOL
Assetmark Inc. Has $39,000 Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Hood River Capital Management LLC Bolsters Stake in AtriCure Inc. - GuruFocus.com
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 31.6% - MarketBeat
AtriCure Inc (ATRC) Stock Price Down 3.06% on Nov 12 - GuruFocus.com
(ATRC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
AtriCure to Participate in the Stifel 2024 Healthcare Conference - StockTitan
A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb - Simply Wall St
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
AtriCure Inc (ATRC) Shares Up 3.58% on Nov 5 - GuruFocus.com
Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN
US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St
AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey
AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St
Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa
Earnings call: AtriCure reports robust growth, raises full-year guidance - Investing.com India
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
AtriCure price target raised to $36 from $32 at Oppenheimer - MSN
AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India
AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat
AtriCure (NASDAQ:ATRC) Given New $53.00 Price Target at Canaccord Genuity Group - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat
AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance
AtriCure: Q3 Earnings Snapshot - The Washington Post
AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com
AtriCure Reports Third Quarter 2024 Financial Results - Business Wire
Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure to Participate in the UBS Global Healthcare Conference - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):